A short course of immunotherapy given before surgery eliminated detectable colon cancer in a majority of patients whose ...

LUND, SE / ACCESS Newswire / July 2, 2026 / Alligator Bioscience (STO:ATORX) First patient dosed in an investigator-initiated ...

There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...

The emergence of immunotherapy for esophageal cancer provided a glimmer of hope to patients and clinicians affected by the historically poor-prognosis disease. The glimmer has not only persisted but ...

After neoadjuvant therapy, ctDNA clearance occurred in 96% of patients ...

NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...

Adding apalutamide to ADT in the adjuvant and neoadjuvant settings improves outcomes in prostate cancer patients undergoing radical prostatectomy.

NEO-CYT positions MDNA11 in a frontline neoadjuvant melanoma setting, where immunotherapy before surgery may help generate deeper and more durable anti-tumor immune responses Up to 80 patients with ...

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) regarding characterization and treatment of central nervous system (CNS) cancers were very recently updated and have expanded the ...

Merck MRK announced that the European Commission has approved its blockbuster PD-L1 inhibitor, Keytruda (pembrolizumab), and ...

Objectives To assess the outcomes of patients undergoing open abdominal surgery at a National Referral Hospital in Tanzania. Design A prospective, observational, single-arm cohort study. Setting Dar ...

Therapeutics Ltd. today announced the public release of its clinical and scientific evidence package for 101-PGC-005 (?005), a macrophage-targeted dexamethasone prodrug designed to modulate pathogenic ...